Authors
Batluk T. I.
Junior researcher, Laboratory for preventive medicine1
Tsygankova O. V.
Doctor of Medicine, researcher, Laboratory for clinical, biochemical and hormonal studies of therapeutic diseases1; Assistant professor, Chair for emergency therapy with endocrinology and occupational pathology, Faculty of advanced training and professional retraining2
Latyntseva L. D.
PhD, Honored Doctor of the Russian Federation, Head, Therapeutic department of Research Institute of Internal and Preventive Medicine clinic1
Platonov D. Y.
Doctor of Medicine, Head, Chair of internal diseases, Faculty of advanced training3, Head, Cardiology department, Tver regional clinic, Chief expert on cardiology, Tver regional MoH
Starichkov A. A.
Doctor of Medicine, Professor, Chair for emergency therapy with endocrinology and occupational pathology, Faculty of advanced training and professional retraining2
1 - Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Science, Novosibirsk, Russia
2 - Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk, Russia;
3 - Tver State Medical University, Ministry of Health of Russia, Tver, Russia
Corresponding author
Tatiana I. Batluk; e-mail: novagirl@mail.ru
Conflict of interest
None declared.
Funding
The study had no sponsorship.
Abstract
A description of the clinical case is given in a 68-year-old patient with elevated erythrocyte sedimentation rate (ESR). The process of diagnostic search is presented with the verification of the clinical diagnosis – multiple myeloma.
Key words
elevated ESR, multiple myeloma
DOI
References
1. Petrov V.I. Klinicheskaya farmakologiya i farmakoterapiya v real'noi vrachebnoi praktike: Master-klass. Uchebnik [Clinical pharmacology and pharmacotherapy in real medical practice: Master class. Textbook]. M.: GEOTAR-Media; 2011: 809-814. (In Russ.)
2. Kishkun A.A. Biokhimicheskie issledovaniya v klinicheskoi praktike: Rukovodstvo dlya vrachei [Biochemical research in clinical practice: A guide for physicians]. M.: OOO «Izdatel'stvo »Meditsinskoe informatsionnoe agenstvo«, 2014: 28-29. (In Russ.)
3. S.S.Bessmel'tsev, K.M. Abdulkadyrov Mnozhestvennaya mieloma: Rukovodstvo dlya vrachei [Multiple myeloma: A guide for physicians]. Moscow: MK, 2016. – 504 s. (In Russ.)
4. Mendeleeva L.P., Votyakova O.M., Pokrovskaya O.S., Rekhtina I.G., Darskaya E.I., Galtseva I.V. et al. National clinical recommendations on diagnosis and treatment of multiple myeloma. Hematology and Transfusiology [National clinical guidelines for the diagnosis and treatment of multiple myeloma]. Gematologiya i transfusiologiya [Haematology and Transfusiology] 2016; 61(1, Suppl. 2): 1-24. doi:10.18821/0234-5730-2016-61-1 (In Russ.)
5. Alexandrakis M.G., Passam F.H., Ganotakis E.S., Sfiridaki K., Xilouri I., Perisinakis K., Kyriakou D.S. The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma. Clinical & Laboratory Haematology 2003; 25 (1): 41-46. doi:10.1046/j.1365-2257.2003.00492.x
6. Hu H., Wang L., Xu H., Peng J., Jia Y. Clinical analysis of six cases of multiple myeloma first presenting with coagulopathy. Blood Coagulation & Fibrinolysis 2014; 25 (6): 553-556. doi: 10.1097/MBC.0000000000000023
7. Landgren O., Iskander K. Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes. Journal of Internal Medicine 2017, 281; 365-382. doi: 10.1111/joim.12590
8. Niels W.C.J. van de Donk, Pieter Sonneveld. Diagnosis and risk stratification in multiple myeloma. Hematology/Oncology Clinics of North America 2014; 28 (5): 791-813. doi: 10.1016/j.hoc.2014.06.007.
9. Kumar S.K., Callander N.S., Alsina M., Atanackovic D., Biermann J.S., Chandler J.C. et al. Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2017; 15 (2) :230-269. doi:10.6004/jnccn.2017.0023
10. Kuroda J., Chinen Y. Multiple myeloma: pathophysiology and progress in management. The Japanese journal of clinical hematology 2017; 58 (5): 487-497. doi:10.11406/rinketsu.58.487.
